Having reaped substantial gains from high-growth tech stocks like AMD and META, we're shifting focus towards undervalued opportunities in China and healthcare. This strategic pivot is fuelled by the desire...
Hims & Hers has witnessed a remarkable 25% stock surge despite parting ways with Novo Nordisk amidst allegations about GLP-1 drugs. This unexpected rally, set against a backdrop of regulatory...
Faced with historical scepticism due to opaque communications, SoFi Technologies has recently pivoted towards greater transparency, just as its share price surged by 20% last month. This strategic shift could...
Explore how SoFi's innovative stock gifting feature is poised to transform retail investing. By making it as effortless as sending cash for a pint, this tool enhances user engagement and...
Witness the dramatic rise of Hims & Hers Health (HIMS) as it ventures into the weight-loss drug market. This telehealth maven has surged over 12% in a single session, driven...
As Hims & Hers Health faces a 30% stock dip, savvy investors are eyeing the robust buying by those with deep pockets, hinting at a potential turnaround. Institutional inflows suggest...
The S&P 500 has achieved an unprecedented all-time high, prompting a blend of optimism and caution among investors. Fuelled by positive trade talks and robust corporate earnings, tech giants like...
Nike faces a pivotal moment as its earnings stumble amidst fierce competition, with revenue misses and lowered guidance signalling challenges ahead. Meanwhile, the S&P 500 ETF ($SPY) maintains a strong...
Nike's stock has impressively sprinted up 14% to $71, driven by a rosy earnings report that defied expectations and reassured investors. Amidst a turbulent retail sector, this rally may indicate...
Hims & Hers Health (HIMS) stock recently surged by 7.5% in a single session, leaving short-sellers in a bit of a pickle. This spike suggests potential turning points in the...
